规格 | 价格 | 库存 | 数量 |
---|---|---|---|
250mg |
|
||
Other Sizes |
|
药代性质 (ADME/PK) |
Absorption, Distribution and Excretion
...(TOLYL-(14)C)CHLORTOLURON WAS ADMIN DAILY TO RATS FOR...2 WK...CONCN OF RADIOACTIVITY IN BLOOD & VARIOUS ORGANS REACHED THEIR HIGHEST LEVEL ON 1ST OR 2ND DAY...& DID NOT INCR FOR REMAINDER OF EXPT. ...WHEN FEEDING OF LABEL WAS ABANDONED, RADIOACTIVITY IN ALL TISSUES DECR BELOW DETECTABLE LEVELS WITHIN...9 DAYS. ...PHENYLUREAS LABELED WITH (14)C IN DIFFERENT POSITIONS WERE ADMIN ORALLY TO RATS, IT WAS OBSERVED THAT TOTAL RADIOACTIVITY WAS RAPIDLY & EFFICIENTLY ELIMINATED IN URINE & FECES. ...90% OR MORE OF RADIOACTIVITY APPLIED WAS ACCOUNTED FOR IN EXCRETA WITHIN 72 HR AFTER ADMIN...(TOLYL-(14)C)CHLORTOLURON. WITH MOST MENTIONED CMPD /(TOLYL-(14)C)CHLORTOLURON/ MAJOR PORTION OF LABEL WAS ELIMINATED IN URINE, WHEREAS AMT OF FECAL RADIOACTIVITY WAS USUALLY NO MORE THAN 20% IN TERMS OF DOSE APPLIED. Metabolism / Metabolites RECOGNIZED N-DEMETHYLATION &/OR N-DEMETHOXYLATION REACTIONS OF PHENYLUREA HERBICIDES IN BIOLOGICAL ENVIRONMENTS--CHLORTOLURON-- SOIL/MICROBIAL MEDIA: IN SILTY CLAY SOIL; PLANTS: IN WHEAT; MAMMALS: IN RAT /FROM TABLE/ ...FATE OF (14)C-TOLYL-LABELED HERBICIDE /CHLORTOLURON/ IN RAT. ...METHYL RING SUBSTITUENT WAS SUBJECTED TO STEPWISE OXIDATION, YIELDING FIRST CORRESPONDING HYDROXYMETHYL AND THEN CARBOXY DERIVATIVE. ... COMBINED N-DEMETHYLATION/SIDE-CHAIN OXIDATION PATHWAY IN RATS IS /SRP: 3-(3-CHLORO-4-HYDROXYMETHYLPHENYL)-1,1-DIMETHYLUREA; 3-(3-CHLORO-4-CARBOXYPHENYL)-1,1-DIMETHYLUREA; 3-(3-CHLORO-4-HYDROXYMETHYLPHENYL)-1-METHYLUREA; 3-(3-CHLORO-4-CARBOXYPHENYL)-1-METHYLUREA; 3-(3-CHLORO-4-HYDROXYMETHYLPHENYL)UREA AND 3-(3-CHLORO-4-CARBOXYPHENYL)UREA/. THE METABOLISM OF CHLORTOLURON IN WHEAT EXHIBITED ESSENTIALLY THE SAME QUALITATIVE PATTERN OF DEGRADATION. HOWEVER, THE MAJOR PORTION OF THE HYDROXYMETHYL METABOLITE (3-(3-CHLORO-4-HYDROXYMETHYLPHENYL)-1,1-DIMETHYLUREA) WAS FIRST TRAPPED AS WATER-SOL CONJUGATE(S). FURTHER OXIDATION TO CORRESPONDING CARBOXY DERIVATIVE OCCURRED ONLY IN LATER STAGES OF PLANT GROWTH. IN ADDN, N-DEMETHYLATION DID NOT PROCEED BEYOND N-MONOMETHYL STAGE. The metabolism of chlortoluron was investigated in several plant species. Chlortoluron was degraded via both N-demethylation and ring-methyl oxidation reactions. The latter pathway was the major degradative route in wheat and barley. Since the products of ring-methyl oxidation are nonphytotoxic, the existence of such a detoxification mechanism in these cereals may account for their enhanced resistance to chlortoluron. The major metabolites in the susceptible cereal weeds, Avena fatua, Alopecurus myosuroides and Lolium perenne, and in resistant cotton were products of N-demethylation. This reaction in the cereal weeds proceeded only very slightly beyond the state the mono-N-demethylated metabolites some of which retain considerable phytotoxicity. In cotton, however, N-demethylation was more efficient, giving rise to substantial amounts of N-didemethylated metabolites which are non-phytotoxic. For more Metabolism/Metabolites (Complete) data for CHLORTOLURON (7 total), please visit the HSDB record page. |
---|---|
毒性/毒理 (Toxicokinetics/TK) |
Interactions
Levels of cytochrome p450s and rates of monooxygenase activities were studied in microsomes prepared from wheat cell suspension cultures. Cytochrome contents and enzymatic activities, namely, the enzymatic systems responsible for chlorotoluron ring-methy1 hydroxy1ation and N-demethylation, were enhanced after pretreatment of cells with 2,4-D, procloraz, mecoprop, chlorotoluron, and oxime ether safeners. Effects of various agrochemicals were also determined on chlorotoluron ring-methyl hydroxylase and N-demethylase, following their direct addition to microsomal preparations. Plant growth regulators and fungicide, as well as piperonyl butoxide decreased both activities, tetcyclacis, and procloraz being marked1y inhibitory. Naphthalic anhydride, oxime ether safeners, dich1ormid, and tridiphane had only weak effects. The substrate specificities of chlorotoluron ring-methyl hydroxylase and N-demethylase were also investigated using structural analogues of the herbicide. Diuron was the strongest inhibitor among the tested phenylureas. Other herbicides that can be metabolized by wheat affected both activities to different extents. However, diclofop enhanced only chlorotoluron N-demethylase. Non-Human Toxicity Values LD50 Rat oral greater than 10000 mg/kg LD50 Rat subcutaneous greater than 2000 mg/kg |
其他信息 |
Chlorotoluron is a member of the class of phenylureas that is urea in which one of the nitrogens is substituted by two methyl groups while the other is substituted by a 3-chloro-4-methylphenyl group. A herbicide that is non-toxic to honeybees but moderately toxic to mammals, birds, earthworms and most aquatic organisms. It has a role as a xenobiotic, an environmental contaminant, an agrochemical and a herbicide. It is a member of monochlorobenzenes and a member of phenylureas.
Mechanism of Action Inhibits photosynthesis. |
分子式 |
C10H13CLN2O
|
---|---|
分子量 |
212.677
|
精确质量 |
212.071
|
CAS号 |
15545-48-9
|
相关CAS号 |
Chlorotoluron-d6;1219803-48-1
|
PubChem CID |
27375
|
外观&性状 |
COLORLESS CRYSTALS
white powder |
密度 |
1.2±0.1 g/cm3
|
沸点 |
345.9±52.0 °C at 760 mmHg
|
熔点 |
147-148ºC
|
闪点 |
163.0±30.7 °C
|
蒸汽压 |
0.0±0.8 mmHg at 25°C
|
折射率 |
1.541
|
LogP |
2.62
|
tPSA |
32.34
|
氢键供体(HBD)数目 |
1
|
氢键受体(HBA)数目 |
1
|
可旋转键数目(RBC) |
1
|
重原子数目 |
14
|
分子复杂度/Complexity |
208
|
定义原子立体中心数目 |
0
|
SMILES |
CC1=C(Cl)C=C(NC(N(C)C)=O)C=C1
|
InChi Key |
JXCGFZXSOMJFOA-UHFFFAOYSA-N
|
InChi Code |
InChI=1S/C10H13ClN2O/c1-7-4-5-8(6-9(7)11)12-10(14)13(2)3/h4-6H,1-3H3,(H,12,14)
|
化学名 |
3-(3-chloro-4-methylphenyl)-1,1-dimethylurea
|
别名 |
Chlorotoluron Dikurin Dicuran
|
HS Tariff Code |
2934.99.9001
|
存储方式 |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month 注意: 本产品在运输和储存过程中需避光。 |
运输条件 |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
溶解度 (体外实验) |
DMSO : ~50 mg/mL (~235.09 mM)
|
---|---|
溶解度 (体内实验) |
注意: 如下所列的是一些常用的体内动物实验溶解配方,主要用于溶解难溶或不溶于水的产品(水溶度<1 mg/mL)。 建议您先取少量样品进行尝试,如该配方可行,再根据实验需求增加样品量。
注射用配方
注射用配方1: DMSO : Tween 80: Saline = 10 : 5 : 85 (如: 100 μL DMSO → 50 μL Tween 80 → 850 μL Saline)(IP/IV/IM/SC等) *生理盐水/Saline的制备:将0.9g氯化钠/NaCl溶解在100 mL ddH ₂ O中,得到澄清溶液。 注射用配方 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (如: 100 μL DMSO → 400 μL PEG300 → 50 μL Tween 80 → 450 μL Saline) 注射用配方 3: DMSO : Corn oil = 10 : 90 (如: 100 μL DMSO → 900 μL Corn oil) 示例: 以注射用配方 3 (DMSO : Corn oil = 10 : 90) 为例说明, 如果要配制 1 mL 2.5 mg/mL的工作液, 您可以取 100 μL 25 mg/mL 澄清的 DMSO 储备液,加到 900 μL Corn oil/玉米油中, 混合均匀。 View More
注射用配方 4: DMSO : 20% SBE-β-CD in Saline = 10 : 90 [如:100 μL DMSO → 900 μL (20% SBE-β-CD in Saline)] 口服配方
口服配方 1: 悬浮于0.5% CMC Na (羧甲基纤维素钠) 口服配方 2: 悬浮于0.5% Carboxymethyl cellulose (羧甲基纤维素) 示例: 以口服配方 1 (悬浮于 0.5% CMC Na)为例说明, 如果要配制 100 mL 2.5 mg/mL 的工作液, 您可以先取0.5g CMC Na并将其溶解于100mL ddH2O中,得到0.5%CMC-Na澄清溶液;然后将250 mg待测化合物加到100 mL前述 0.5%CMC Na溶液中,得到悬浮液。 View More
口服配方 3: 溶解于 PEG400 (聚乙二醇400) 请根据您的实验动物和给药方式选择适当的溶解配方/方案: 1、请先配制澄清的储备液(如:用DMSO配置50 或 100 mg/mL母液(储备液)); 2、取适量母液,按从左到右的顺序依次添加助溶剂,澄清后再加入下一助溶剂。以 下列配方为例说明 (注意此配方只用于说明,并不一定代表此产品 的实际溶解配方): 10% DMSO → 40% PEG300 → 5% Tween-80 → 45% ddH2O (或 saline); 假设最终工作液的体积为 1 mL, 浓度为5 mg/mL: 取 100 μL 50 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀/澄清;向上述体系中加入50 μL Tween-80,混合均匀/澄清;然后继续加入450 μL ddH2O (或 saline)定容至 1 mL; 3、溶剂前显示的百分比是指该溶剂在最终溶液/工作液中的体积所占比例; 4、 如产品在配制过程中出现沉淀/析出,可通过加热(≤50℃)或超声的方式助溶; 5、为保证最佳实验结果,工作液请现配现用! 6、如不确定怎么将母液配置成体内动物实验的工作液,请查看说明书或联系我们; 7、 以上所有助溶剂都可在 Invivochem.cn网站购买。 |
制备储备液 | 1 mg | 5 mg | 10 mg | |
1 mM | 4.7019 mL | 23.5095 mL | 47.0190 mL | |
5 mM | 0.9404 mL | 4.7019 mL | 9.4038 mL | |
10 mM | 0.4702 mL | 2.3509 mL | 4.7019 mL |
1、根据实验需要选择合适的溶剂配制储备液 (母液):对于大多数产品,InvivoChem推荐用DMSO配置母液 (比如:5、10、20mM或者10、20、50 mg/mL浓度),个别水溶性高的产品可直接溶于水。产品在DMSO 、水或其他溶剂中的具体溶解度详见上”溶解度 (体外)”部分;
2、如果您找不到您想要的溶解度信息,或者很难将产品溶解在溶液中,请联系我们;
3、建议使用下列计算器进行相关计算(摩尔浓度计算器、稀释计算器、分子量计算器、重组计算器等);
4、母液配好之后,将其分装到常规用量,并储存在-20°C或-80°C,尽量减少反复冻融循环。
计算结果:
工作液浓度: mg/mL;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL)。如该浓度超过该批次药物DMSO溶解度,请首先与我们联系。
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。
(1) 请确保溶液澄清之后,再加入下一种溶剂 (助溶剂) 。可利用涡旋、超声或水浴加热等方法助溶;
(2) 一定要按顺序加入溶剂 (助溶剂) 。